Published in Cell on August 03, 2012
Brown and beige fat: development, function and therapeutic potential. Nat Med (2013) 5.29
What we talk about when we talk about fat. Cell (2014) 4.12
Adaptive thermogenesis in adipocytes: is beige the new brown? Genes Dev (2013) 3.74
PPARγ signaling and metabolism: the good, the bad and the future. Nat Med (2013) 3.71
SIRT1 and other sirtuins in metabolism. Trends Endocrinol Metab (2013) 1.90
Calorie restriction and sirtuins revisited. Genes Dev (2013) 1.79
Brown and Beige Fat: Physiological Roles beyond Heat Generation. Cell Metab (2015) 1.60
Myostatin knockout drives browning of white adipose tissue through activating the AMPK-PGC1α-Fndc5 pathway in muscle. FASEB J (2013) 1.54
The different shades of fat. Nature (2014) 1.53
Thiazolidinediones and the promise of insulin sensitization in type 2 diabetes. Cell Metab (2014) 1.53
Transcriptional and epigenetic control of brown and beige adipose cell fate and function. Nat Rev Mol Cell Biol (2016) 1.53
A Synergistic Antiobesity Effect by a Combination of Capsinoids and Cold Temperature Through Promoting Beige Adipocyte Biogenesis. Diabetes (2016) 1.43
Sirtuins: guardians of mammalian healthspan. Trends Genet (2014) 1.36
SIRT1 and energy metabolism. Acta Biochim Biophys Sin (Shanghai) (2013) 1.25
Inducible brown adipose tissue, or beige fat, is anabolic for the skeleton. Endocrinology (2013) 1.18
Oxidative stress and metabolic pathologies: from an adipocentric point of view. Oxid Med Cell Longev (2014) 1.16
Turning WAT into BAT: a review on regulators controlling the browning of white adipocytes. Biosci Rep (2013) 1.14
The sirtuin family's role in aging and age-associated pathologies. J Clin Invest (2013) 1.12
PPARα and Sirt1 mediate erythropoietin action in increasing metabolic activity and browning of white adipocytes to protect against obesity and metabolic disorders. Diabetes (2013) 1.12
Altered miRNA processing disrupts brown/white adipocyte determination and associates with lipodystrophy. J Clin Invest (2014) 1.12
Adipose tissue plasticity from WAT to BAT and in between. Biochim Biophys Acta (2013) 1.12
The importance of NAMPT/NAD/SIRT1 in the systemic regulation of metabolism and ageing. Diabetes Obes Metab (2013) 1.10
MicroRNA 34a inhibits beige and brown fat formation in obesity in part by suppressing adipocyte fibroblast growth factor 21 signaling and SIRT1 function. Mol Cell Biol (2014) 1.09
Brown and Beige Fat: Molecular Parts of a Thermogenic Machine. Diabetes (2015) 1.07
The Effects of High Fat Diet and Resveratrol on Mitochondrial Activity of Brown Adipocytes. Endocrinol Metab (Seoul) (2016) 1.06
SIRT1 in Type 2 Diabetes: Mechanisms and Therapeutic Potential. Diabetes Metab J (2013) 1.05
The Roles of SIRT1 in Cancer. Genes Cancer (2013) 1.04
Brown adipose tissue: development, metabolism and beyond. Biochem J (2013) 1.03
Resveratrol increases brown adipose tissue thermogenesis markers by increasing SIRT1 and energy expenditure and decreasing fat accumulation in adipose tissue of mice fed a standard diet. Eur J Nutr (2014) 1.02
The brain and brown fat. Ann Med (2014) 1.02
The REGγ proteasome regulates hepatic lipid metabolism through inhibition of autophagy. Cell Metab (2013) 1.01
Dominant negative PPARγ promotes atherosclerosis, vascular dysfunction, and hypertension through distinct effects in endothelium and vascular muscle. Am J Physiol Regul Integr Comp Physiol (2013) 1.00
Metabolic stress modulates Alzheimer's β-secretase gene transcription via SIRT1-PPARγ-PGC-1 in neurons. Cell Metab (2013) 0.98
Deleted in breast cancer-1 (DBC-1) in the interface between metabolism, aging and cancer. Biosci Rep (2013) 0.98
Protein acetylation in metabolism - metabolites and cofactors. Nat Rev Endocrinol (2015) 0.97
Taking control over intracellular fatty acid levels is essential for the analysis of thermogenic function in cultured primary brown and brite/beige adipocytes. EMBO Rep (2014) 0.96
Metabolic inflexibility impairs insulin secretion and results in MODY-like diabetes in triple FoxO-deficient mice. Cell Metab (2014) 0.96
SIRT1 in the brain-connections with aging-associated disorders and lifespan. Front Cell Neurosci (2015) 0.93
Differentiation of hypothalamic-like neurons from human pluripotent stem cells. J Clin Invest (2015) 0.93
Adipocyte SIRT1 knockout promotes PPARγ activity, adipogenesis and insulin sensitivity in chronic-HFD and obesity. Mol Metab (2015) 0.92
Distinct populations of adipogenic and myogenic Myf5-lineage progenitors in white adipose tissues. J Lipid Res (2013) 0.91
Transcriptional Regulatory Circuits Controlling Brown Fat Development and Activation. Diabetes (2015) 0.91
EBF2 promotes the recruitment of beige adipocytes in white adipose tissue. Mol Metab (2015) 0.91
High-fat diet-induced impairment of skeletal muscle insulin sensitivity is not prevented by SIRT1 overexpression. Am J Physiol Endocrinol Metab (2014) 0.90
Depletion of white adipocyte progenitors induces beige adipocyte differentiation and suppresses obesity development. Cell Death Differ (2014) 0.90
Adipocytes under assault: environmental disruption of adipose physiology. Biochim Biophys Acta (2013) 0.89
Nuclear receptors rock around the clock. EMBO Rep (2014) 0.89
SIRT1 is a Highly Networked Protein That Mediates the Adaptation to Chronic Physiological Stress. Genes Cancer (2013) 0.89
Crosstalk between poly(ADP-ribose) polymerase and sirtuin enzymes. Mol Aspects Med (2013) 0.89
Recent advance in brown adipose physiology and its therapeutic potential. Exp Mol Med (2014) 0.88
Molecular mechanisms regulating vascular tone by peroxisome proliferator activated receptor gamma. Curr Opin Nephrol Hypertens (2015) 0.87
Glucocorticoids transcriptionally regulate miR-27b expression promoting body fat accumulation via suppressing the browning of white adipose tissue. Diabetes (2014) 0.87
Control of brown and beige fat development. Nat Rev Mol Cell Biol (2016) 0.86
Inhibition of HDAC3 promotes ligand-independent PPARγ activation by protein acetylation. J Mol Endocrinol (2014) 0.86
Regulation of SIRT1 by microRNAs. Mol Cells (2013) 0.86
Convertible visceral fat as a therapeutic target to curb obesity. Nat Rev Drug Discov (2016) 0.85
Selective overexpression of human SIRT1 in adipose tissue enhances energy homeostasis and prevents the deterioration of insulin sensitivity with ageing in mice. Am J Transl Res (2013) 0.85
Resveratrol Inhibits CD4+ T cell activation by enhancing the expression and activity of Sirt1. PLoS One (2013) 0.85
Revisiting PPARγ as a target for the treatment of metabolic disorders. BMB Rep (2014) 0.85
The Role of SIRT1 in Diabetic Kidney Disease. Front Endocrinol (Lausanne) (2014) 0.84
Structural basis for specific ligation of the peroxisome proliferator-activated receptor δ. Proc Natl Acad Sci U S A (2017) 0.84
Capsaicin induces browning of white adipose tissue and counters obesity by activating TRPV1 channel-dependent mechanisms. Br J Pharmacol (2016) 0.83
Follistatin promotes adipocyte differentiation, browning, and energy metabolism. J Lipid Res (2014) 0.83
Carboxamide SIRT1 inhibitors block DBC1 binding via an acetylation-independent mechanism. Cell Cycle (2013) 0.83
SIRT1 is a direct coactivator of thyroid hormone receptor β1 with gene-specific actions. PLoS One (2013) 0.83
KSRP ablation enhances brown fat gene program in white adipose tissue through reduced miR-150 expression. Diabetes (2014) 0.83
SIRT1 enhances glucose tolerance by potentiating brown adipose tissue function. Mol Metab (2014) 0.83
Resveratrol and its metabolites bind to PPARs. Chembiochem (2014) 0.83
Targeting adipose tissue in the treatment of obesity-associated diabetes. Nat Rev Drug Discov (2016) 0.83
Exploring the emerging complexity in transcriptional regulation of energy homeostasis. Nat Rev Genet (2015) 0.83
Of mice and men: novel insights regarding constitutive and recruitable brown adipocytes. Int J Obes Suppl (2015) 0.82
Functions of Prdm16 in thermogenic fat cells. Temperature (Austin) (2015) 0.82
Curcumin analogues as selective fluorescence imaging probes for brown adipose tissue and monitoring browning. Sci Rep (2015) 0.82
Acupuncture promotes white adipose tissue browning by inducing UCP1 expression on DIO mice. BMC Complement Altern Med (2014) 0.82
Regulatory networks of non-coding RNAs in brown/beige adipogenesis. Biosci Rep (2015) 0.82
Nuclear Mechanisms of Insulin Resistance. Trends Cell Biol (2016) 0.81
Partial agonist, telmisartan, maintains PPARγ serine 112 phosphorylation, and does not affect osteoblast differentiation and bone mass. PLoS One (2014) 0.81
Brown fat determination and development from muscle precursor cells by novel action of bone morphogenetic protein 6. PLoS One (2014) 0.81
LPS-Enhanced Glucose-Stimulated Insulin Secretion Is Normalized by Resveratrol. PLoS One (2016) 0.81
Comprehensive molecular characterization of human adipocytes reveals a transient brown phenotype. J Transl Med (2015) 0.81
Deleted in breast cancer 1 (DBC1) protein regulates hepatic gluconeogenesis. J Biol Chem (2014) 0.80
Nuclear receptors and epigenetic regulation: opportunities for nutritional targeting and disease prevention. Adv Nutr (2014) 0.80
Identification of a mammalian glycerol-3-phosphate phosphatase: Role in metabolism and signaling in pancreatic β-cells and hepatocytes. Proc Natl Acad Sci U S A (2016) 0.79
A New Role for Browning as a Redox and Stress Adaptive Mechanism? Front Endocrinol (Lausanne) (2015) 0.79
PPARγ neddylation essential for adipogenesis is a potential target for treating obesity. Cell Death Differ (2016) 0.79
Erythropoietin alleviates hepatic insulin resistance via PPARγ-dependent AKT activation. Sci Rep (2015) 0.79
Acetylation-defective mutant of Pparγ is associated with decreased lipid synthesis in breast cancer cells. Oncotarget (2014) 0.79
FABP4-Cre Mediated Expression of Constitutively Active ChREBP Protects Against Obesity, Fatty Liver, and Insulin Resistance. Endocrinology (2015) 0.79
Age-associated changes in long-chain fatty acid profile during healthy aging promote pro-inflammatory monocyte polarization via PPARγ. Aging Cell (2015) 0.78
Chrysophanic Acid Suppresses Adipogenesis and Induces Thermogenesis by Activating AMP-Activated Protein Kinase Alpha In vivo and In vitro. Front Pharmacol (2016) 0.78
Nuclear receptors and AMPK: can exercise mimetics cure diabetes? J Mol Endocrinol (2016) 0.78
Deleted in breast cancer 1 limits adipose tissue fat accumulation and plays a key role in the development of metabolic syndrome phenotype. Diabetes (2014) 0.77
Transcriptional control and hormonal response of thermogenic fat. J Endocrinol (2015) 0.77
SIRT1 Limits Adipocyte Hyperplasia through c-Myc Inhibition. J Biol Chem (2015) 0.77
Suppression of PPARγ-mediated monoacylglycerol O-acyltransferase 1 expression ameliorates alcoholic hepatic steatosis. Sci Rep (2016) 0.77
Aldehyde dehydrogenase 1a3 defines a subset of failing pancreatic β cells in diabetic mice. Nat Commun (2016) 0.77
Hepatic SirT1-Dependent Gain of Function of Stearoyl-CoA Desaturase-1 Conveys Dysmetabolic and Tumor Progression Functions. Cell Rep (2015) 0.76
Autophagy and cardiometabolic risk factors. Rev Endocr Metab Disord (2014) 0.76
Skeletal integration of energy homeostasis: Translational implications. Bone (2015) 0.76
AMP-Activated Kinase (AMPK) Activation by AICAR in Human White Adipocytes Derived from Pericardial White Adipose Tissue Stem Cells Induces a Partial Beige-Like Phenotype. PLoS One (2016) 0.76
Resveratrol improves mitochondrial function and protects against metabolic disease by activating SIRT1 and PGC-1alpha. Cell (2006) 19.16
A PGC1-α-dependent myokine that drives brown-fat-like development of white fat and thermogenesis. Nature (2012) 14.67
PRDM16 controls a brown fat/skeletal muscle switch. Nature (2008) 13.08
Calorie restriction promotes mammalian cell survival by inducing the SIRT1 deacetylase. Science (2004) 11.39
Health and economic burden of the projected obesity trends in the USA and the UK. Lancet (2011) 10.73
AMPK regulates energy expenditure by modulating NAD+ metabolism and SIRT1 activity. Nature (2009) 10.59
Sirt1 promotes fat mobilization in white adipocytes by repressing PPAR-gamma. Nature (2004) 10.32
Small molecule activators of SIRT1 as therapeutics for the treatment of type 2 diabetes. Nature (2007) 10.21
Ligand binding and co-activator assembly of the peroxisome proliferator-activated receptor-gamma. Nature (1998) 8.33
Prdm16 determines the thermogenic program of subcutaneous white adipose tissue in mice. J Clin Invest (2010) 6.96
A SUMOylation-dependent pathway mediates transrepression of inflammatory response genes by PPAR-gamma. Nature (2005) 6.83
Dominant negative mutations in human PPARgamma associated with severe insulin resistance, diabetes mellitus and hypertension. Nature (2000) 5.86
FGF21 regulates PGC-1α and browning of white adipose tissues in adaptive thermogenesis. Genes Dev (2012) 5.71
The forkhead transcription factor Foxo1 regulates adipocyte differentiation. Dev Cell (2003) 5.59
The mammalian SIR2alpha protein has a role in embryogenesis and gametogenesis. Mol Cell Biol (2003) 5.38
FOXC2 is a winged helix gene that counteracts obesity, hypertriglyceridemia, and diet-induced insulin resistance. Cell (2001) 5.22
Anti-diabetic drugs inhibit obesity-linked phosphorylation of PPARgamma by Cdk5. Nature (2010) 5.01
SirT1 gain of function increases energy efficiency and prevents diabetes in mice. Cell Metab (2008) 4.89
DBC1 is a negative regulator of SIRT1. Nature (2008) 4.66
SRC-1 and TIF2 control energy balance between white and brown adipose tissues. Cell (2002) 4.31
Negative regulation of the deacetylase SIRT1 by DBC1. Nature (2008) 4.29
Adipose tissue reduction in mice lacking the translational inhibitor 4E-BP1. Nat Med (2001) 4.19
FoxO1 protects against pancreatic beta cell failure through NeuroD and MafA induction. Cell Metab (2005) 4.14
Calorie restriction-like effects of 30 days of resveratrol supplementation on energy metabolism and metabolic profile in obese humans. Cell Metab (2011) 3.69
Fibroblast growth factor-21 regulates PPARγ activity and the antidiabetic actions of thiazolidinediones. Cell (2012) 3.07
Protein acetylation microarray reveals that NuA4 controls key metabolic target regulating gluconeogenesis. Cell (2009) 2.99
The vascular endothelium of the adipose tissue gives rise to both white and brown fat cells. Cell Metab (2012) 2.97
Rb and p107 regulate preadipocyte differentiation into white versus brown fat through repression of PGC-1alpha. Cell Metab (2005) 2.76
Suppression of oxidative metabolism and mitochondrial biogenesis by the transcriptional corepressor RIP140 in mouse adipocytes. J Clin Invest (2005) 2.69
Adipocyte-specific transcription factor ARF6 is a heterodimeric complex of two nuclear hormone receptors, PPAR gamma and RXR alpha. Nucleic Acids Res (1994) 2.58
Identification of a domain within peroxisome proliferator-activated receptor gamma regulating expression of a group of genes containing fibroblast growth factor 21 that are selectively repressed by SIRT1 in adipocytes. Mol Cell Biol (2007) 2.12
Degradation of the peroxisome proliferator-activated receptor gamma is linked to ligand-dependent activation. J Biol Chem (2000) 2.10
C/EBPalpha and the corepressors CtBP1 and CtBP2 regulate repression of select visceral white adipose genes during induction of the brown phenotype in white adipocytes by peroxisome proliferator-activated receptor gamma agonists. Mol Cell Biol (2009) 1.98
Deleted in breast cancer-1 regulates SIRT1 activity and contributes to high-fat diet-induced liver steatosis in mice. J Clin Invest (2010) 1.97
Functional interaction between peroxisome proliferator-activated receptor gamma and beta-catenin. Mol Cell Biol (2006) 1.95
Brown fat and the myth of diet-induced thermogenesis. Cell Metab (2010) 1.82
Sympathetic and sensory innervation of brown adipose tissue. Int J Obes (Lond) (2010) 1.71
Uncoupling of acetylation from phosphorylation regulates FoxO1 function independent of its subcellular localization. J Biol Chem (2010) 1.68
The LXXLL motif of murine forkhead transcription factor FoxO1 mediates Sirt1-dependent transcriptional activity. J Clin Invest (2006) 1.62
Increased insulin sensitivity despite lipodystrophy in Crebbp heterozygous mice. Nat Genet (2002) 1.44
The implication of brown adipose tissue for humans. Annu Rev Nutr (2011) 1.32
Proatherogenic abnormalities of lipid metabolism in SirT1 transgenic mice are mediated through Creb deacetylation. Cell Metab (2011) 1.23
Structural insight into PPARgamma activation through covalent modification with endogenous fatty acids. J Mol Biol (2008) 1.21
Revisiting the rosiglitazone story--lessons learned. N Engl J Med (2010) 1.21
Obesity: Be cool, lose weight. Nature (2009) 1.08
Dynamic interactions and cooperative functions of PGC-1alpha and MED1 in TRalpha-mediated activation of the brown-fat-specific UCP-1 gene. Mol Cell (2009) 1.07
Cell biology. Selective insulin sensitizers. Science (2011) 0.94
Brown adipose tissue in humans. Curr Opin Lipidol (2011) 0.93
FGF21 and the second coming of PPARγ. Cell (2012) 0.81
Obesity is associated with macrophage accumulation in adipose tissue. J Clin Invest (2003) 41.22
Substrate and functional diversity of lysine acetylation revealed by a proteomics survey. Mol Cell (2006) 11.38
Insulin-regulated hepatic gluconeogenesis through FOXO1-PGC-1alpha interaction. Nature (2003) 9.77
Modes of p53 regulation. Cell (2009) 9.31
Mammalian SIRT1 represses forkhead transcription factors. Cell (2004) 8.89
Deubiquitination of p53 by HAUSP is an important pathway for p53 stabilization. Nature (2002) 7.71
Acetylation is indispensable for p53 activation. Cell (2008) 5.70
Tip60-dependent acetylation of p53 modulates the decision between cell-cycle arrest and apoptosis. Mol Cell (2006) 5.64
The forkhead transcription factor Foxo1 regulates adipocyte differentiation. Dev Cell (2003) 5.59
p53 ubiquitination: Mdm2 and beyond. Mol Cell (2006) 5.57
Ubiquitination, phosphorylation and acetylation: the molecular basis for p53 regulation. Curr Opin Cell Biol (2003) 5.46
SIRT1 transgenic mice show phenotypes resembling calorie restriction. Aging Cell (2007) 5.30
Identification of 67 histone marks and histone lysine crotonylation as a new type of histone modification. Cell (2011) 5.27
Jarid2/Jumonji coordinates control of PRC2 enzymatic activity and target gene occupancy in pluripotent cells. Cell (2009) 5.26
Mono- versus polyubiquitination: differential control of p53 fate by Mdm2. Science (2003) 5.23
The long-term stability of the human gut microbiota. Science (2013) 5.15
RalB GTPase-mediated activation of the IkappaB family kinase TBK1 couples innate immune signaling to tumor cell survival. Cell (2006) 5.08
Tumor suppressor HIC1 directly regulates SIRT1 to modulate p53-dependent DNA-damage responses. Cell (2005) 5.04
Tumor suppression in the absence of p53-mediated cell-cycle arrest, apoptosis, and senescence. Cell (2012) 4.96
SirT1 gain of function increases energy efficiency and prevents diabetes in mice. Cell Metab (2008) 4.89
Pancreatic β cell dedifferentiation as a mechanism of diabetic β cell failure. Cell (2012) 4.88
Regulation of insulin action and pancreatic beta-cell function by mutated alleles of the gene encoding forkhead transcription factor Foxo1. Nat Genet (2002) 4.76
Impaired regulation of hepatic glucose production in mice lacking the forkhead transcription factor Foxo1 in liver. Cell Metab (2007) 4.74
ARF-BP1/Mule is a critical mediator of the ARF tumor suppressor. Cell (2005) 4.60
Non-transcriptional control of DNA replication by c-Myc. Nature (2007) 4.55
Lysine acetylation is a highly abundant and evolutionarily conserved modification in Escherichia coli. Mol Cell Proteomics (2008) 4.36
Crystal structure of a UBP-family deubiquitinating enzyme in isolation and in complex with ubiquitin aldehyde. Cell (2002) 4.33
Negative regulation of the deacetylase SIRT1 by DBC1. Nature (2008) 4.29
FoxO1 protects against pancreatic beta cell failure through NeuroD and MafA induction. Cell Metab (2005) 4.14
Nuclear trapping of the forkhead transcription factor FoxO1 via Sirt-dependent deacetylation promotes expression of glucogenetic genes. J Biol Chem (2005) 4.13
The forkhead transcription factor Foxo1 links insulin signaling to Pdx1 regulation of pancreatic beta cell growth. J Clin Invest (2002) 4.05
A dynamic role of HAUSP in the p53-Mdm2 pathway. Mol Cell (2004) 4.05
Chinese hamster ovary K2 cell lipid droplets appear to be metabolic organelles involved in membrane traffic. J Biol Chem (2003) 3.90
Distinctive roles of PHAP proteins and prothymosin-alpha in a death regulatory pathway. Science (2003) 3.59
Estimating the changes in energy flux that characterize the rise in obesity prevalence. Am J Clin Nutr (2009) 3.56
JMJD6 is a histone arginine demethylase. Science (2007) 3.48
Acetylation of p53 inhibits its ubiquitination by Mdm2. J Biol Chem (2002) 3.37
Structure-based prediction of protein-protein interactions on a genome-wide scale. Nature (2012) 3.37
Complete rescue of obesity, diabetes, and infertility in db/db mice by neuron-specific LEPR-B transgenes. J Clin Invest (2005) 3.29
Forkhead protein FoxO1 mediates Agrp-dependent effects of leptin on food intake. Nat Med (2006) 3.24
Dual role of transcription factor FoxO1 in controlling hepatic insulin sensitivity and lipid metabolism. J Clin Invest (2006) 3.21
How does SIRT1 affect metabolism, senescence and cancer? Nat Rev Cancer (2008) 3.17
Macrophage insulin receptor deficiency increases ER stress-induced apoptosis and necrotic core formation in advanced atherosclerotic lesions. Cell Metab (2006) 3.14
Non-invasive prenatal measurement of the fetal genome. Nature (2012) 3.11
Lysine propionylation and butyrylation are novel post-translational modifications in histones. Mol Cell Proteomics (2007) 3.09
Acetylation of p53 augments its site-specific DNA binding both in vitro and in vivo. Proc Natl Acad Sci U S A (2004) 3.06
Parc: a cytoplasmic anchor for p53. Cell (2003) 3.06
Acetylation inactivates the transcriptional repressor BCL6. Nat Genet (2002) 3.00
Protein acetylation microarray reveals that NuA4 controls key metabolic target regulating gluconeogenesis. Cell (2009) 2.99
CHD7 cooperates with PBAF to control multipotent neural crest formation. Nature (2010) 2.88
Identification of lysine succinylation as a new post-translational modification. Nat Chem Biol (2010) 2.87
Interactions between E2F1 and SirT1 regulate apoptotic response to DNA damage. Nat Cell Biol (2006) 2.85
Upregulation of myocellular DGAT1 augments triglyceride synthesis in skeletal muscle and protects against fat-induced insulin resistance. J Clin Invest (2007) 2.85
The first identification of lysine malonylation substrates and its regulatory enzyme. Mol Cell Proteomics (2011) 2.83
Dynamic activity of lipid droplets: protein phosphorylation and GTP-mediated protein translocation. J Proteome Res (2007) 2.76
Generation of functional insulin-producing cells in the gut by Foxo1 ablation. Nat Genet (2012) 2.75
A tagging-via-substrate technology for detection and proteomics of farnesylated proteins. Proc Natl Acad Sci U S A (2004) 2.74
Functional analysis of the roles of posttranslational modifications at the p53 C terminus in regulating p53 stability and activity. Mol Cell Biol (2005) 2.72
Induction of pluripotency in mouse somatic cells with lineage specifiers. Cell (2013) 2.69
Reduced expression of the murine p85alpha subunit of phosphoinositide 3-kinase improves insulin signaling and ameliorates diabetes. J Clin Invest (2002) 2.65
A local mechanism mediates NAD-dependent protection of axon degeneration. J Cell Biol (2005) 2.64
SIRT1 deacetylation and repression of p300 involves lysine residues 1020/1024 within the cell cycle regulatory domain 1. J Biol Chem (2005) 2.59
A Foxo/Notch pathway controls myogenic differentiation and fiber type specification. J Clin Invest (2007) 2.57
p53 post-translational modification: deregulated in tumorigenesis. Trends Mol Med (2010) 2.54
Structural basis of competitive recognition of p53 and MDM2 by HAUSP/USP7: implications for the regulation of the p53-MDM2 pathway. PLoS Biol (2006) 2.35
PPARgamma2 regulates lipogenesis and lipid accumulation in steatotic hepatocytes. Am J Physiol Endocrinol Metab (2005) 2.34
Nearly finished genomes produced using gel microdroplet culturing reveal substantial intraspecies genomic diversity within the human microbiome. Genome Res (2013) 2.29
Integrated approach for manual evaluation of peptides identified by searching protein sequence databases with tandem mass spectra. J Proteome Res (2005) 2.27
Peroxisome-proliferator-activated receptor gamma suppresses Wnt/beta-catenin signalling during adipogenesis. Biochem J (2003) 2.26
Activation of MEK/ERK signaling promotes adipogenesis by enhancing peroxisome proliferator-activated receptor gamma (PPARgamma ) and C/EBPalpha gene expression during the differentiation of 3T3-L1 preadipocytes. J Biol Chem (2002) 2.21
Prevalence of diagnosed and undiagnosed type 2 diabetes mellitus among US adolescents: results from the continuous NHANES, 1999-2010. Am J Epidemiol (2013) 2.20
Adiponectin secretion is regulated by SIRT1 and the endoplasmic reticulum oxidoreductase Ero1-L alpha. Mol Cell Biol (2007) 2.17
SIRT5-mediated lysine desuccinylation impacts diverse metabolic pathways. Mol Cell (2013) 2.17
Mouse models of insulin resistance. Physiol Rev (2004) 2.16
Insulin/Foxo1 pathway regulates expression levels of adiponectin receptors and adiponectin sensitivity. J Biol Chem (2004) 2.15
Overview of the Alliance for Cellular Signaling. Nature (2002) 2.15
Hormonal regulation of hepatic glucose production in health and disease. Cell Metab (2011) 2.12
Identification of a domain within peroxisome proliferator-activated receptor gamma regulating expression of a group of genes containing fibroblast growth factor 21 that are selectively repressed by SIRT1 in adipocytes. Mol Cell Biol (2007) 2.12
Acetylation of yeast AMPK controls intrinsic aging independently of caloric restriction. Cell (2011) 2.10
Roles of histone acetylation and chromatin remodeling factor in a meiotic recombination hotspot. EMBO J (2004) 2.08
NIH working group report: Innovative research to improve maintenance of weight loss. Obesity (Silver Spring) (2014) 2.08
Inhibition of Foxo1 function is associated with improved fasting glycemia in diabetic mice. Am J Physiol Endocrinol Metab (2003) 2.06
Both carboxy-terminus NES motif and mutated tryptophan(s) are crucial for aberrant nuclear export of nucleophosmin leukemic mutants in NPMc+ AML. Blood (2006) 2.06
An intimate collaboration between peroxisomes and lipid bodies. J Cell Biol (2006) 2.04
FoxO1 target Gpr17 activates AgRP neurons to regulate food intake. Cell (2012) 2.03
A comprehensive synthetic genetic interaction network governing yeast histone acetylation and deacetylation. Genes Dev (2008) 2.01
Microfluidics for flow cytometric analysis of cells and particles. Physiol Meas (2005) 2.00
2-deoxy-D-glucose enhances anesthetic effects in mice. Anesth Analg (2015) 1.99
C/EBPalpha and the corepressors CtBP1 and CtBP2 regulate repression of select visceral white adipose genes during induction of the brown phenotype in white adipocytes by peroxisome proliferator-activated receptor gamma agonists. Mol Cell Biol (2009) 1.98